The Dark Genome Therapeutics market, valued at USD 2,155.7 million in 2024, is expected to register robust revenue CAGR of 23.8%.Request free copy of this report: 01, 2025 - Integration of AI and ...

Mursla’s AI Precision Medicine is built on the ability to isolate and analyze EVs which are secreted by specific organs into ...

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized ...

The conscious beauty revolution accelerates: 68% of brands adopt animal-free actives (Ecovia 2025) as #VeganSkincare surges ...

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized ...

Almost all cervical cancers are caused by human papillomaviruses (HPVs). In most cases, HPV DNA is integrated into the human genome. We found that tumor-specific, HPV-human DNA junctions are ...

The tumor suppressor p53 is a transcription factor that controls the expression of hundreds of genes. Emerging evidence suggests that the p53-induced RNA-binding protein ZMAT3 is a key splicing ...

TAIZHOU CITY, ZHEJIANG, CHINA, June 25, 2025 /EINPresswire.com/ -- The China National Intellectual Property Administration (CNIPA) announced the winners of the 25th China Patent Awards. Zhejiang ...

The Innovation Center of NanoMedicine has summarized the results of its collaborative research with Professor Kanjiro ...

The Global Core Clinical Molecular Diagnostics Market is valued at approximately USD 5.26 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 9.5% over the forecast ...

PDF for business studies from the official Punjab Board website. Access chapter-wise details for business studies with the link to download the PDF, and more to plan your studies effectively ...